Kasahara et al., 2001 - Google Patents
A missense mutation in the Na+/glucose cotransporter gene SGLT1 in a patient with congenital glucose-galactose malabsorption: normal trafficking but inactivation of …Kasahara et al., 2001
View HTML- Document ID
- 4527472815047418103
- Author
- Kasahara M
- Maeda M
- Hayashi S
- Mori Y
- Abe T
- Publication year
- Publication venue
- Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease
External Links
Snippet
The Na+/glucose cotransporter gene SGLT1 was analyzed in a Japanese patient with congenital glucose-galactose malabsorption. Genomic DNA was used as a template for amplification by the polymerase chain reaction of each of the 15 exons of SGLT1. The …
- 101710040671 SLC5A1 0 title abstract description 56
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kasahara et al. | A missense mutation in the Na+/glucose cotransporter gene SGLT1 in a patient with congenital glucose-galactose malabsorption: normal trafficking but inactivation of the mutant protein | |
Jung et al. | Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice | |
Ala et al. | Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. | |
De Deken et al. | Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family | |
Halestrap et al. | The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation | |
Nogee | Genetics of the hydrophobic surfactant proteins | |
Chou et al. | The SLC37 family of sugar-phosphate/phosphate exchangers | |
Manzoni et al. | Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization | |
Suchy et al. | Bile acid transport across the hepatocyte canalicular membrane | |
Sweadner | Overview: subunit diversity in the Na, K-ATPase | |
US20100105625A1 (en) | Product and Methods for Diagnosis and Therapy for Cardiac and Skeletal Muscle Disorders | |
US7972601B2 (en) | Method of promoting delivery of an antioxidant agent to a cell expression neuroligin | |
Vijayasarathy et al. | Molecular mechanisms leading to null‐protein product from retinoschisin (RS1) signal‐sequence mutants in X‐linked retinoschisis (XLRS) disease | |
Jacob et al. | Hierarchy of sorting signals in chimeras of intestinal lactase-phlorizin hydrolase and the influenza virus hemagglutinin | |
Maselli et al. | Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering | |
Coumailleau et al. | Over-expression of Rififylin, a new RING finger and FYVE-like domain-containing protein, inhibits recycling from the endocytic recycling compartment | |
Weber et al. | Na, K-ATPase subunit β1 knock-in prevents lethality of β2 deficiency in mice | |
Okawa et al. | A novel loss-of-function mutation of GATA3 (p. R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome | |
Zhang et al. | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum | |
EP1263982A1 (en) | Phosphatidyl serine receptors and uses thereof | |
Wakabayashi et al. | Second mutations rescue point mutant of the Na+/H+ exchanger NHE1 showing defective surface expression | |
CA2647769C (en) | Control of intracellular target molecule by ip3 receptor-binding protein | |
Zhao et al. | Accumulation of βm, a structural member of X, K-ATPase β-subunit family, in nuclear envelopes of perinatal myocytes | |
US6821750B2 (en) | ABCG8 vectors, host cells, and method of making | |
Jeck et al. | Loop disorders: insights derived from defined genotypes |